The Genetics of Primary Biliary Cholangitis: A GWAS and Post-GWAS Update
Open accessAbstract
Primary biliary cholangitis (PBC) is a chronic, progressive cholestatic liver disease in which the small intrahepatic bile ducts are destroyed by autoimmune reactions. Among autoimmune diseases, which are polygenic complex traits caused by the combined contribution of genetic and environmental factors, PBC exhibits the strongest involvement of genetic heritability in disease development. As at December 2022, genome-wide association studies (GWASs) and associated meta-analyses identified approximately 70 PBC susceptibility gene loci in various populations, including those of European and East Asian descent. However, the molecular mechanisms through which these susceptibility loci affect the pathogenesis of PBC are not fully understood. This study provides an overview of current data regarding the genetic factors of PBC as well as post-GWAS approaches to identifying primary functional variants and effector genes in disease-susceptibility loci. Possible mechanisms of these genetic factors in the development of PBC are also discussed, focusing on four major disease pathways identified by in silico gene set analyses, namely, (1) antigen presentation by human leukocyte antigens, (2) interleukin-12-related pathways, (3) cellular responses to tumor necrosis factor, and (4) B cell activation, maturation, and differentiation pathways.
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
Characteristic HLA regions linked to primary biliary cholangitis susceptibility include HLA class 2 alleles, principally HLA-DRB6, HLA-DQA2, and HLA-DRB1.
“Characteristic HLA regions linked to primary biliary cholangitis susceptibility include HLA class 2 alleles, principally HLA-DRB6, HLA-DQA2, and HLA-DRB1.11”
From Primary biliary cholangitis. (2024) · cites this paper as [11]
Section 2.1 (page not provided) links HLA class II alleles to PBC susceptibility and identifies predisposing HLA-DRB1 alleles. It does not identify HLA-DRB6 or HLA-DQA2 as susceptibility alleles; it names HLA-DQA1 and HLA-DQB1 alleles instead. (LLM, conf=0.88)
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Cites
Szklarczyk, D., Gable, A. L., Nastou, K. C., Lyon, D., Kirsch, R., Pyysalo, S., Doncheva, N. T., Legeay, M., Fang, T., Bork, P., et al. (2021) · Nucleic Acids Research · doi:10.1093/nar/gkaa1074 · Cited by 8,056 · see citing works
Global quantification of mammalian gene expression control
Schwanhäusser, B., Busse, D., Li, N., Dittmar, G., Schuchhardt, J., Wolf, J., Chen, W., & Selbach, M. (2011) · Nature · doi:10.1038/nature10098 · Cited by 6,566 · cited 1× · see citing works
“Additionally, for more accurate post-GWAS analysis, protein–QTL analysis, an approach derived from a novel proteomics assay capable of measuring thousands of human protein analytes, enables accurate determination of correlations between variants and expression levels, without the uncertainty of e-QTL data that results…”
BackgroundThe HCV Life Cycle: In vitro Tissue Culture Systems and Therapeutic Targets
Gerold, G., & Pietschmann, T. (2014) · Digestive Diseases · doi:10.1159/000360830 · Cited by 4,854 · see citing works
Genetic variation in IL28B predicts hepatitis C treatment-induced viral clearance
Ge, D., Fellay, J., Thompson, A. J. V., Simon, J. S., Shianna, K. V., Urban, T. J., Heinzen, E. L., Qiu, P., Bertelsen, A. H., Muir, A. J., et al. (2009) · Nature · doi:10.1038/nature08309 · Cited by 3,510 · see citing works
The NHGRI GWAS Catalog, a curated resource of SNP-trait associations
Welter, D., MacArthur, J., Morales, J., Burdett, T., Hall, P., Junkins, H., Klemm, A., Flicek, P., Manolio, T., Hindorff, L., et al. (2014) · Nucleic Acids Research · doi:10.1093/nar/gkt1229 · Cited by 2,707 · see citing works
Genetics of rheumatoid arthritis contributes to biology and drug discovery
the RACI consortium, Okada, Y., the GARNET consortium, Wu, D., Trynka, G., Raj, T., Terao, C., Ikari, K., Kochi, Y., Ohmura, K., et al. (2014) · Nature · doi:10.1038/nature12873 · Cited by 2,310 · see citing works
Tanaka, Y., Nishida, N., Sugiyama, M., Kurosaki, M., Matsuura, K., Sakamoto, N., Nakagawa, M., Korenaga, M., Hino, K., Hige, S., et al. (2009) · Nature Genetics · doi:10.1038/ng.449 · Cited by 2,141 · see citing works
Kaplan, M. M. (1987) · New England Journal of Medicine · doi:10.1056/nejm198702263160907 · Cited by 2,015 · see citing works
IL28B is associated with response to chronic hepatitis C interferon-α and ribavirin therapy
Study, F. T. H. C., Suppiah, V., Moldovan, M. V., Ahlenstiel, G., Berg, T., Weltman, M., Abate, M. L., Bassendine, M. F., Spengler, U., Dore, G. J., et al. (2009) · Nature Genetics · doi:10.1038/ng.447 · Cited by 1,807 · see citing works
Kaplan, M. M., & Gershwin, M. E. (2005) · New England Journal of Medicine · doi:10.1056/nejmra043898 · Cited by 1,144 · see citing works
Mapping the human genetic architecture of COVID-19
Initiative, C.-1. H. G., InitiativeLeadership, C.-1. H. G., Niemi, M., Karjalainen, J. M., Liao, R. G., Neale, B. M., Daly, M. J., Ganna, A., Writing group, Writing group leaders, et al. (2021) · Nature · doi:10.1038/s41586-021-03767-x · Cited by 970 · see citing works
Caspase‐8: regulating life and death
Tummers, B., & Green, D. R. (2017) · Immunological Reviews · doi:10.1111/imr.12541 · Cited by 754 · see citing works
Primary Biliary Cirrhosis Associated with <i>HLA, IL12A,</i> and <i>IL12RB2</i> Variants
Hirschfield, G. M., Liu, X., Xu, C., Lu, Y., Xie, G., Lu, Y., Gu, X., Walker, E. J., Jing, K., Juran, B. D., et al. (2009) · New England Journal of Medicine · doi:10.1056/nejmoa0810440 · Cited by 594 · see citing works
From evolutionary genetics to human immunology: how selection shapes host defence genes
Barreiro, L. B., & Quintana‐Murci, L. (2009) · Nature Reviews Genetics · doi:10.1038/nrg2698 · Cited by 556 · see citing works
Primary biliary cirrhosis in monozygotic and dizygotic twins: Genetics, epigenetics, and environment
Selmi, C., Mayo, M. J., Bach, N., Ishibashi, H., Invernizzi, P., Gish, R. G., Gordon, S. C., Wright, H. I., Zweiban, B., Podda, M., et al. (2004) · Gastroenterology · doi:10.1053/j.gastro.2004.05.005 · Cited by 480 · see citing works
Genome-wide association study identifies 12 new susceptibility loci for primary biliary cirrhosis
The UK PBC Consortium, Mells, G. F., The Wellcome Trust Case Control Consortium 3, Floyd, J. A. B., Morley, K. I., Cordell, H. J., Franklin, C. S., Shin, S.-Y., Heneghan, M. A., Neuberger, J. M., et al. (2011) · Nature Genetics · doi:10.1038/ng.789 · Cited by 464 · see citing works
Szklarczyk, D., Gable, A. L., Nastou, K. C., Lyon, D., Kirsch, R. L., Pyysalo, S., Doncheva, N. T., Legeay, M., Fang, T., Peer Bork, B., et al. (2021) · Nucleic Acids Research · doi:10.1093/nar/gkab835 · Cited by 450 · see citing works
ITPA gene variants protect against anaemia in patients treated for chronic hepatitis C
Fellay, J., Thompson, A. J., Ge, D., Gumbs, C. E., Urban, T. J., Shianna, K. V., Little, L. D., Qiu, P., Bertelsen, A. H., Watson, M., et al. (2010) · Nature · doi:10.1038/nature08825 · Cited by 441 · see citing works
Genome-wide meta-analyses identify three loci associated with primary biliary cirrhosis
Liu, X., Invernizzi, P., Lu, Y., Kosoy, R., Lu, Y., Bianchi, I., Podda, M., Xu, C., Xie, G., Macciardi, F., et al. (2010) · Nature Genetics · doi:10.1038/ng.627 · Cited by 398 · see citing works
Selmi, C., Bowlus, C. L., Gershwin, M. E., & Coppel, R. L. (2011) · The Lancet · doi:10.1016/s0140-6736(10)61965-4 · Cited by 334 · see citing works
Dynamic landscape of immune cell-specific gene regulation in immune-mediated diseases
Ota, M., Nagafuchi, Y., Hatano, H., Ishigaki, K., Terao, C. C., Takeshima, Y., Yanaoka, H., Kobayashi, S., Okubo, M., Shirai, H., et al. (2021) · Cell · doi:10.1016/j.cell.2021.03.056 · Cited by 322 · see citing works
Shimoda, S., Nakamura, M., Ishibashi, H., Hayashida, K., & Niho, Y. (1995) · The Journal of Experimental Medicine · doi:10.1084/jem.181.5.1835 · Cited by 304 · see citing works
Self-citationCordell, H. J., Han, Y., Mells, G. F., Li, Y., Hirschfield, G. M., Greene, C. S., Xie, G., Juran, B. D., Zhu, D., Qian, D. C., et al. (2015) · Nature Communications · doi:10.1038/ncomms9019 · Cited by 287 · see citing works
Dense fine-mapping study identifies new susceptibility loci for primary biliary cirrhosis
The UK Primary Biliary Cirrhosis (PBC) Consortium, Liu, J. Z., The Wellcome Trust Case Control Consortium 3, Almarri, M. A., Gaffney, D. J., Mells, G. F., Jostins, L., Cordell, H. J., Ducker, S. J., Day, D. B., et al. (2012) · Nature Genetics · doi:10.1038/ng.2395 · Cited by 274 · see citing works
The causes of primary biliary cirrhosis: Convenient and inconvenient truths
Gershwin, E. M., & Mackay, I. R. (2007) · Hepatology · doi:10.1002/hep.22042 · Cited by 273 · see citing works
Nakamura, M., Nishida, N., Kawashima, M., Aiba, Y., Tanaka, A., Yasunami, M., Nakamura, H., Komori, A., Nakamuta, M., Zeniya, M., et al. (2012) · The American Journal of Human Genetics · doi:10.1016/j.ajhg.2012.08.010 · Cited by 267 · see citing works
Self-citationThe Genotype-Tissue Expression (GTEx) project
Lonsdale, J., Thomas, J., Salvatore, M., Phillips, R., Lo, E., Shad, S., Hasz, R., Walters, G., Garcia, F., Young, N., et al. (2013) · Nature Genetics · doi:10.1038/ng.2653 · Cited by 263 · see citing works
Shimoda, S., de Water, J. V., Ansari, A. A., Nakamura, M., Ishibashi, H., Coppel, R. L., Lake, J. R., Keeffe, E. B., Roche, T. E., & Gershwin, M. E. (1998) · Journal of Clinical Investigation · doi:10.1172/jci4213 · Cited by 250 · see citing works
Self-citationDemographic, lifestyle, medical and familial factors associated with primary biliary cirrhosis
Corpechot, C., Chrétien, Y., Chazouillères, O., & Poupon, R. (2010) · Journal of Hepatology · doi:10.1016/j.jhep.2010.02.019 · Cited by 235 · see citing works
Variants at IRF5-TNPO3, 17q12-21 and MMEL1 are associated with primary biliary cirrhosis
Hirschfield, G. M., Liu, X., Han, Y., Gorlov, I. P., Lu, Y., Xu, C., Lu, Y., Chen, W., Juran, B. D., Coltescu, C., et al. (2010) · Nature Genetics · doi:10.1038/ng.631 · Cited by 215 · see citing works
Familial primary biliary cirrhosis reassessed: a geographically-based population study
Jones, D. E., Watt, F. E., Metcalf, J. V., Bassendine, M. F., & James, O. F. W. (1999) · Journal of Hepatology · doi:10.1016/s0168-8278(99)80097-x · Cited by 213 · see citing works
Clinical significance and immunobiology of IL-21 in autoimmunity
Long, D., Chen, Y., Wu, H., Zhao, M., & Lu, Q. (2019) · Journal of Autoimmunity · doi:10.1016/j.jaut.2019.01.013 · Cited by 197 · see citing works
Cordell, H. J., Fryett, J. J., Ueno, K., Darlay, R., Aiba, Y., Hitomi, Y., Kawashima, M., Nishida, N., Khor, S.-S., Gervais, O., et al. (2021) · Journal of Hepatology · doi:10.1016/j.jhep.2021.04.055 · Cited by 182 · see citing works
Self-citationImamura, M., Takahashi, A., Yamauchi, T., Hara, K., Yasuda, K., Grarup, N., Zhao, W., Wang, X., Huerta‐Chagoya, A., Hu, C., et al. (2016) · Nature Communications · doi:10.1038/ncomms10531 · Cited by 174 · see citing works
Vondenhoff, M. F. R., Greuter, M., Goverse, G., Elewaut, D. S., Dewint, P., Ware, C. F., Hoorweg, K., Kraal, G., & Mebius, R. E. (2009) · The Journal of Immunology · doi:10.4049/jimmunol.0801165 · Cited by 153 · see citing works
Juran, B. D., Hirschfield, G. M., Invernizzi, P., Atkinson, E. J., Li, Y., Xie, G., Kosoy, R., Ransom, M., Sun, Y., Bianchi, I., et al. (2012) · Human Molecular Genetics · doi:10.1093/hmg/dds359 · Cited by 150 · see citing works
Primary biliary cirrhosis and Sjögren’s syndrome: Autoimmune epithelitis
Selmi, C., Meroni, P. L., & Gershwin, M. E. (2012) · Journal of Autoimmunity · doi:10.1016/j.jaut.2011.11.005 · Cited by 145 · see citing works
A genome-wide association study identifies six novel risk loci for primary biliary cholangitis
Qiu, F., Tang, R., Zuo, X., Shi, X., Wei, Y., Zheng, X., Dai, Y., Gong, Y., Wang, L., Xu, P., et al. (2017) · Nature Communications · doi:10.1038/ncomms14828 · Cited by 140 · see citing works
Antimitochondrial Antibodies in Primary Biliary Cirrhosis
Leung, P. S. C., Coppel, R. L., Ansari, A. A., Muñoz, S. J., & Gershwin, M. E. (1997) · Seminars in Liver Disease · doi:10.1055/s-2007-1007183 · Cited by 139 · see citing works
Donaldson, P. T., Baragiotta, A. M., Heneghan, M. A., Floreani, A., Venturi, C., Underhill, J. A., Jones, D. E. J., James, O., & Bassendine, M. F. (2006) · Hepatology · doi:10.1002/hep.21316 · Cited by 136 · see citing works
Cortés, M., & Georgopoulos, K. (2004) · The Journal of Experimental Medicine · doi:10.1084/jem.20031571 · Cited by 135 · see citing works
Invernizzi, P., Selmi, C., Poli, F., Frison, S., Floreani, A., Alvaro, D., Almasio, P., Rosina, F., Marzioni, M., Fabris, L., et al. (2008) · Hepatology · doi:10.1002/hep.22567 · Cited by 130 · see citing works
Donaldson, P. T., Agarwal, K., Craggs, A., Craig, W., James, O., & Jones, D. (2001) · Gut · doi:10.1136/gut.48.3.397 · Cited by 124 · see citing works
Bae, H. R., Leung, P. S. C., Tsuneyama, K., Valencia, J. C., Hodge, D. L., Kim, S., Back, T., Karwan, M., Merchant, A. S., Baba, N., et al. (2016) · Hepatology · doi:10.1002/hep.28641 · Cited by 121 · see citing works
CXCR5+ T cells: follicular homing takes center stage in T-helper-cell responses
Moser, B., Schaerli, P., & Loetscher, P. (2002) · Trends in Immunology · doi:10.1016/s1471-4906(02)02218-4 · Cited by 116 · see citing works
Honda, A., Tanaka, A., Kaneko, T., Komori, A., Abe, M., Inao, M., Namisaki, T., Hashimoto, N., Kawata, K., Takahashi, A., et al. (2019) · Hepatology · doi:10.1002/hep.30552 · Cited by 116 · see citing works
Enhanced expression of type I interferon and toll-like receptor-3 in primary biliary cirrhosis
Takii, Y., Nakamura, M., Ito, M., Yokoyama, T., Komori, A., Shimizu‐Yoshida, Y., Nakao, R., Kusumoto, K., Nagaoka, S., Yano, K., et al. (2005) · Laboratory Investigation · doi:10.1038/labinvest.3700285 · Cited by 114 · see citing works
Self-citationThe immune system, bone and RANKL
Guerrini, M. M., & Takayanagi, H. (2014) · Archives of Biochemistry and Biophysics · doi:10.1016/j.abb.2014.06.003 · Cited by 107 · see citing works
Cerutti, A., Schaffer, A., Goodwin, R. G., Shah, S., Zan, H., Ely, S. A., & Casali, P. (2000) · The Journal of Immunology · doi:10.4049/jimmunol.165.2.786 · Cited by 96 · see citing works
Hirschfield, G. M., Xie, G., Lu, E., Sun, Y., Juran, B. D., Chellappa, V, Coltescu, C., Mason, A. L., Milkiewicz, P., Myers, R. P., et al. (2012) · Genes & Immunity · doi:10.1038/gene.2011.89 · Cited by 85 · see citing works
Natural killer cells regulate T cell immune responses in primary biliary cirrhosis
Shimoda, S., Hisamoto, S., Harada, K., Iwasaka, S., Chong, Y., Nakamura, M., Bekki, Y., Yoshizumi, T., Shirabe, K., Ikegami, T., et al. (2015) · Hepatology · doi:10.1002/hep.28122 · Cited by 82 · see citing works
Self-citationKakuda, Y., Harada, K., Sawada-Kitamura, S., Ikeda, H., Sato, Y., Sasaki, M., Okafuji, H., Mizukoshi, E., Terasaki, S., Ohta, H., et al. (2013) · Human Pathology · doi:10.1016/j.humpath.2012.09.017 · Cited by 81 · see citing works
Hanada, S., Harada, M., Koga, H., Kawaguchi, T., 谷口英太郎, Kumashiro, R., Takato, U., Ueno, Y., Ishii, M., Sakisaka, S., et al. (2003) · Liver International · doi:10.1034/j.1600-0676.2003.01707.x · Cited by 76 · see citing works
Umemura, T., Joshita, S., Ichijo, T., Yoshizawa, K., Katsuyama, Y., Tanaka, E., & Ôta, M. (2011) · Hepatology · doi:10.1002/hep.24705 · Cited by 74 · see citing works
Clinical Significance of Autoantibodies in Primary Biliary Cirrhosis
Nakamura, M. (2014) · Seminars in Liver Disease · doi:10.1055/s-0034-1383732 · Cited by 69 · see citing works
Self-citationKhor, S., Yang, W., Kawashima, M., Kamitsuji, S., Zheng, X., Nishida, N., Sawai, H., Toyoda, H., Miyagawa, T., Honda, M., et al. (2015) · The Pharmacogenomics Journal · doi:10.1038/tpj.2015.4 · Cited by 55 · see citing works
X Chromosome Contribution to the Genetic Architecture of Primary Biliary Cholangitis
Asselta, R., Paraboschi, E. M., Gerussi, A., Cordell, H. J., Mells, G. F., Sandford, R. N., Jones, D. E., Nakamura, M., Ueno, K., Hitomi, Y., et al. (2021) · Gastroenterology · doi:10.1053/j.gastro.2021.02.061 · Cited by 55 · see citing works
Self-citationLymphotoxin: from the physiology to the regeneration of the thymic function
Borelli, A., & Irla, M. (2021) · Cell Death and Differentiation · doi:10.1038/s41418-021-00834-8 · Cited by 53 · see citing works
Nakamura, M., Yasunami, M., Kondo, H., Horie, H., Aiba, Y., Komori, A., Migita, K., Yatsuhashi, H., Ito, M., Shimoda, S., et al. (2010) · Hepatology Research · doi:10.1111/j.1872-034x.2010.00631.x · Cited by 52 · see citing works
Self-citationKawashima, M., Hitomi, Y., Aiba, Y., Nishida, N., Kojima, K., Kawai, Y., Nakamura, H., Tanaka, A., Zeniya, M., Hashimoto, E., et al. (2017) · Human Molecular Genetics · doi:10.1093/hmg/ddw406 · Cited by 52 · see citing works
Self-citationChalayer, É., Gramont, B., Zekre, F., Goguyer‐Deschaumes, R., Waeckel, L., Grange, L., Paul, S., Chung, A. W., & Killian, M. (2021) · Autoimmunity Reviews · doi:10.1016/j.autrev.2021.103016 · Cited by 48 · see citing works
Hitomi, Y., Kojima, K., Kawashima, M., Kawai, Y., Nishida, N., Aiba, Y., Yasunami, M., Nagasaki, M., Nakamura, M., & Tokunaga, K. (2017) · Scientific Reports · doi:10.1038/s41598-017-03067-3 · Cited by 43 · see citing works
Self-citationThe immunobiology of female predominance in primary biliary cholangitis
Gerussi, A., Cristoferi, L., Carbone, M., Asselta, R., & Invernizzi, P. (2018) · Journal of Autoimmunity · doi:10.1016/j.jaut.2018.10.015 · Cited by 41 · see citing works
HLA-genotyping of clinical specimens using Ion Torrent-based NGS
Barone, J. C., Saito, K., Beutner, K. R., Campo, M., Dong, W., Goswami, C. P., Johnson, E. S., Wang, Z., & Hsu, S. H. (2015) · Human Immunology · doi:10.1016/j.humimm.2015.09.014 · Cited by 40 · see citing works
Aiba, Y., Harada, K., Komori, A., Ito, M., Shimoda, S., Nakamura, H., Nagaoka, S., Abiru, S., Migita, K., Ishibashi, H., et al. (2013) · Liver International · doi:10.1111/liv.12296 · Cited by 37 · see citing works
Self-citationHuman leukocyte antigen class II alleles in Caucasian women with primary biliary cirrhosis
Mullarkey, M. E., Stevens, A. M., McDonnell, W. M., Loubiere, L., Brackensick, J. A., Pang, J. M., Porter, A. J., Galloway, D. A., & Nelson, J. L. (2005) · Tissue Antigens · doi:10.1111/j.1399-0039.2005.00351.x · Cited by 36 · see citing works
Use of Genome-Wide Association Studies for Cancer Research and Drug Repositioning
Zhang, J., Jiang, K., Lv, L., Wang, H., Shen, Z., Gao, Z., Wang, B., Yang, Y., Ye, Y., & Wang, S. (2015) · PLoS ONE · doi:10.1371/journal.pone.0116477 · Cited by 35 · see citing works
HLA class II markers and clinical heterogeneity in Swedish patients with primary biliary cirrhosis
Waßmuth, R., Depner, F., Danielsson, A., Hultcrantz, R., Lööf, L., Olson, R., Prytz, H., Sandberg–Gertzén, H., Wallerstedt, S. M., & Lindgren, S. C. (2002) · Tissue Antigens · doi:10.1034/j.1399-0039.2002.590504.x · Cited by 34 · see citing works
FCRL regulation in innate‐like B cells
Davis, R. S. (2015) · Annals of the New York Academy of Sciences · doi:10.1111/nyas.12771 · Cited by 31 · see citing works
Yasunami, M., Nakamura, H., Tokunaga, K., Kawashima, M., Nishida, N., Hitomi, Y., & Nakamura, M. (2017) · Scientific Reports · doi:10.1038/s41598-017-11148-6 · Cited by 31 · see citing works
Self-citationThe genetic architecture of primary biliary cholangitis
Gerussi, A., Carbone, M., Corpechot, C., Schramm, C., Asselta, R., & Invernizzi, P. (2021) · European Journal of Medical Genetics · doi:10.1016/j.ejmg.2021.104292 · Cited by 31 · see citing works
Hitomi, Y., Kawashima, M., Aiba, Y., Nishida, N., Matsuhashi, M., Okazaki, H., Nakamura, M., & Tokunaga, K. (2015) · Human Genetics · doi:10.1007/s00439-015-1556-3 · Cited by 30 · see citing works
Self-citationHitomi, Y., Nakatani, K., Kojima, K., Nishida, N., Kawai, Y., Kawashima, M., Aiba, Y., Nagasaki, M., Nakamura, M., & Tokunaga, K. (2018) · Cellular and Molecular Gastroenterology and Hepatology · doi:10.1016/j.jcmgh.2018.11.006 · Cited by 29 · see citing works
Self-citationHitomi, Y., Ueno, K., Kawai, Y., Nishida, N., Kojima, K., Kawashima, M., Aiba, Y., Nakamura, H., Kouno, H., Kouno, H., et al. (2019) · Scientific Reports · doi:10.1038/s41598-018-36490-1 · Cited by 29 · see citing works
Self-citationWang, C., Zheng, X., Tang, R., Han, C., Jiang, Y., Wu, J. H., Shao, Y., Gao, Y., Yu, J., Hu, Z., et al. (2019) · Journal of Autoimmunity · doi:10.1016/j.jaut.2019.102372 · Cited by 25 · see citing works
Zhou, Y., Liu, X., Xu, L., Hunter, Z. R., Cao, Y., Yang, G., Carrasco, R. D., & Treon, S. P. (2014) · British Journal of Haematology · doi:10.1111/bjh.12936 · Cited by 22 · see citing works
Ueno, K., Aiba, Y., Hitomi, Y., Shimoda, S., Nakamura, H., Gervais, O., Kawai, Y., Kawashima, M., Nishida, N., Kohn, S.-S., et al. (2020) · Hepatology Communications · doi:10.1002/hep4.1497 · Cited by 21 · see citing works
Self-citationZhao, D., Liao, H., Zhang, X., Liu, Y., Zhao, Y., Zhang, H., Sun, L., Yin-xue, M., & Yan, H.-P. (2013) · Liver International · doi:10.1111/liv.12236 · Cited by 20 · see citing works
Hitomi, Y., Aiba, Y., Ueno, K., Nishida, N., Kawai, Y., Kawashima, M., Tsuiji, M., Iwabuchi, C., Takada, S., Miyake, N., et al. (2022) · Human Genomics · doi:10.1186/s40246-022-00419-7 · Cited by 18 · see citing works
Self-citationHitomi, Y., Aiba, Y., Kawai, Y., Kojima, K., Ueno, K., Nishida, N., Kawashima, M., Gervais, O., Khor, S., Nagasaki, M., et al. (2021) · Scientific Reports · doi:10.1038/s41598-021-84042-x · Cited by 12 · see citing works
Self-citationGervais, O., Ueno, K., Kawai, Y., Hitomi, Y., Aiba, Y., Ueta, M., Nakamura, M., Tokunaga, K., & Nagasaki, M. (2021) · European Journal of Human Genetics · doi:10.1038/s41431-021-00854-5 · Cited by 12 · see citing works
Self-citationNew insights on the role of human leukocyte antigen complex in primary biliary cholangitis
Mulinacci, G., Palermo, A., Gerussi, A., Asselta, R., Gershwin, M. E., & Invernizzi, P. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.975115 · Cited by 12 · see citing works
Nishida, N., Aiba, Y., Hitomi, Y., Kawashima, M., Kojima, K., Kawai, Y., Ueno, K., Nakamura, H., Yamashiki, N., Tanaka, T., et al. (2018) · Scientific Reports · doi:10.1038/s41598-018-26369-6 · Cited by 11 · see citing works
Self-citationrs9459874 and rs1012656 in CCR6/FGFR1OP confer susceptibility to primary biliary cholangitis
Hitomi, Y., Aiba, Y., Ueno, K., Nishida, N., Kawai, Y., Kawashima, M., Yasunami, M., Gervais, O., Ito, M., Cordell, H. J., et al. (2021) · Journal of Autoimmunity · doi:10.1016/j.jaut.2021.102775 · Cited by 11 · see citing works
Self-citationKawai, Y., Hitomi, Y., Ueta, M., Khor, S., Nakatani, K., Sotozono, C., Kinoshita, S., Nagasaki, M., & Tokunaga, K. (2021) · npj Genomic Medicine · doi:10.1038/s41525-021-00171-2 · Cited by 10 · see citing works
Self-citationHuman immune system diversity and its implications in diseases
Tsuchiya, N., & Ohashi, J. (2015) · Journal of Human Genetics · doi:10.1038/jhg.2015.101 · Cited by 5 · see citing works
Flagged first, then by citations
1 of the 87 references couldn’t be matched to a known paper.
Research works printed but not linked: 1
- [41]Kawashima M. Hitomi Y. Aiba Y. Nishida N. Kojima K. Kawai Y. Nakamura H. Tanaka A. Zeniya M. Hashimoto E. Genome-wide association study identified PRKCB as a genetic susceptibility locus for primary biliary cholangitis in a Japanese population Hum. Mol. Genet. 2017 26 650 659 28062665
Cited by
Sorted by citations
Tanaka, A., Ma, X., Takahashi, A., & Vierling, J. M. (2024) · The Lancet · doi:10.1016/s0140-6736(24)01303-5 · Cited by 177 · see citing works
Mechanism-based target therapy in primary biliary cholangitis: opportunities before liver cirrhosis?
Yang, Y., He, X.-S., Rojas, M., Leung, P. S. C., & Gao, L. (2023) · Frontiers in Immunology · doi:10.3389/fimmu.2023.1184252 · Cited by 29 · see citing works
Fernandes, B. S., Enduru, N., Fernandes, B., Bahrami, S., Dai, Y., Andreassen, O. A., & Zhao, Z. (2024) · Molecular Psychiatry · doi:10.1038/s41380-024-02510-y · Cited by 24 · see citing works
Houri, I., & Hirschfield, G. M. (2023) · Clinics in Liver Disease · doi:10.1016/j.cld.2023.06.006 · Cited by 26 · see citing works
Zhou, T., Ismail, A., & Francis, H. (2023) · Cells · doi:10.3390/cells12232725 · Cited by 14 · see citing works
Reasons why women are more likely to develop primary biliary cholangitis
Ma, D., Ma, J., Zhao, C., & Tai, W. (2024) · Heliyon · doi:10.1016/j.heliyon.2024.e25634 · Cited by 14 · see citing works
Hitomi, Y., Ueno, K., Aiba, Y., Nishida, N., Kono, M., Sugihara, M., Kawai, Y., Kawashima, M., Khor, S., Sugi, K., et al. (2024) · Hepatology · doi:10.1097/hep.0000000000000894 · Cited by 14 · see citing works
Self-citationYang, R., Yao, X., Tang, X., Liu, Y., Yang, X., Ma, H., Kuang, Y., Jiang, T., Qiao, J., & Wei, M. (2025) · Sensors and Actuators B Chemical · doi:10.1016/j.snb.2025.137684 · Cited by 9 · see citing works
The Treatment of Primary Biliary Cholangitis: Time for Personalized Medicine
Men, X., Liu, Y., Zhao, H., Xie, B., Guo, C., Leung, P. S. C., Timilsina, S., Gershwin, M. E., Shang, Y., & Han, Y. (2025) · Clinical Reviews in Allergy & Immunology · doi:10.1007/s12016-025-09074-x · Cited by 8 · see citing works
Hitomi, Y., Ueno, K., Aiba, Y., Nishida, N., Kawai, Y., Kawashima, M., Khor, S., Takada, S., Iwabuchi, C., Nagasaki, M., et al. (2023) · Human Genetics · doi:10.1007/s00439-023-02617-2 · Cited by 6 · see citing works
Self-citationKatsumi, T., Sato, H., Murakami, R., Hanatani, T., Uchiyama, F., Suzuki, F., Maki, K., Hoshikawa, K. T., Haga, H., Saito, T., et al. (2024) · PLoS ONE · doi:10.1371/journal.pone.0308912 · Cited by 4 · see citing works
Zhang, H., Zhou, Z., Chen, K., Xiong, L.-F., Wu, J., & Jin, L. (2024) · BMC Gastroenterology · doi:10.1186/s12876-024-03319-3 · Cited by 4 · see citing works
Primary Biliary Cholangitis Pathogenesis: A Pathophysiology-Based Narrative Review
Papachristou, K., Angelara, M., Manganas, K., & Ανδρουτσάκος, Θ. (2026) · International Journal of Molecular Sciences · doi:10.3390/ijms27031388 · Cited by 3 · see citing works
Bauer, A., & Habior, A. (2025) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2024.1410282 · Cited by 1 · see citing works
Emerging Therapeutics for Primary Biliary Cholangitis
Cho, E. J. (2025) · Korean Journal of Gastroenterology · doi:10.4166/kjg.2025.045 · Cited by 1 · see citing works
The power of genetics in decoding Sjögren’s disease: current status and future development
Radziszewski, M., Tessneer, K. L., & Lessard, C. J. (2025) · Current Opinion in Immunology · doi:10.1016/j.coi.2025.102690 · Cited by 1 · see citing works
Maihemuti, M., Nuermaimaiti, M., Maimaitiming, W., Paierhati, A., Ji, H., Abduwaki, M., Yang, X., & Mohammadtursun, N. (2026) · Pharmaceuticals · doi:10.3390/ph19010153 · Cited by 1 · see citing works
Chen, J., Lyu, Y., Huang, W., Li, Z., Yang, L., Yu, S., Zeng, R., Deng, Y., Liang, Z., Wang, J., et al. (2025) · Research Square · doi:10.21203/rs.3.rs-7186861/v1 · Cited by 1 · see citing works
Research Progress in the Treatment of Primary Biliary Cholangitis with Chinese and Western Medicine
陈, 坤. (2024) · Traditional Chinese Medicine · doi:10.12677/tcm.2024.132041
Hitomi, Y. (2024) · Major Histocompatibility Complex · doi:10.12667/mhc.31.20
Self-citationWang, Y., Zhou, Z., & Zhang, H. (2024) · Medicine · doi:10.1097/md.0000000000038282
Immunology of Autoimmune Liver Diseases
Kayani, K., Bozward, A. G., Davies, S. P., Jeyaraj, R., Asif, A., & Oo, Y. H. (2025) · Elsevier eBooks · doi:10.1016/b978-0-12-824465-4.00173-3
Microbiome-immune interactions in autoimmune liver diseases
Kiseleva, Y. V., Maslennikov, R. V., Poluektova, E. A., Zolnikova, O., Sigidaev, A. S., Zharikov, Y. O., Shirokova, E. N., & Ivashkin, V. (2026) · World Journal of Gastroenterology · doi:10.3748/wjg.v32.i12.115853
Bian, S., Yang, Y., Chen, Z., Wang, L., Chen, H., Liu, S., He, C., Li, Y., Zhang, X., & Zhang, F. (2026) · Cell & Bioscience · doi:10.1186/s13578-026-01589-w
Hitomi, Y., Aiba, Y., Ueno, K., Takahashi, H., Kono, M., Sugi, K., Teraoka, Y., Takaki, S., Naganuma, A., Kojima, M., et al. (2026) · Journal of Gastroenterology · doi:10.1007/s00535-026-02493-3
Self-citationOrchestrated cell death pathways in cholangiopathies
Guicciardi, M. E., Pistorio, V., Soret, P., Steunou, V., Gores, G. J., & Gautheron, J. (2026) · Gut · doi:10.1136/gutjnl-2026-339264
- Authors
- Hitomi, Y., & Nakamura, M.
- Affiliations
- National Center for Global Health and Medicine (JP)
- Nagasaki Medical Center (JP)
- Corresponding author
- Hitomi, Yuki
- ORCID
- Hitomi, Yuki
- Venue
- Genes
- Publisher
- MDPI AG
- Published
- 2023-02-03
- Volume
- 14
- Issue
- 2
- Pages
- 405
- ISSN
- 2073-4425 (ISSN-L)
- PMC
- PMC9957238
- OpenAlex
- W4319317419
- Cited by
- 26
- References
- 87
- Citations by year
- 2026: 6 · 2025: 7 · 2024: 9 · 2023: 4
- FWCI
- 1.12
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- Locations
- Genes (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- Funders
- Japan Society for the Promotion of Science (22K08065, 19K08413, 17H04169)
- Clinical Research from the NHO (22K08065, 19K08413, 17H04169)
- Ministry of Health, Labour, and Welfare of Japan (22K08065, 19K08413, 17H04169)
- Takeda Foundation (22K08065, 19K08413, 17H04169)
- Topics
- Health Sciences › Medicine › Hepatology › Liver Diseases and Immunity
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Genetic Associations and Epidemiology
- Health Sciences › Medicine › Surgery › Pediatric Hepatobiliary Diseases and Treatments
- Keywords
- primary biliary cirrhosis, genetic susceptibility, genetic susceptibility loci, autoimmune liver disease, B cell activation, pathogenesis, functional variants, gene set analysis
- MeSH terms
- Autoimmune Diseases, Cell Differentiation, Humans, Liver Cirrhosis, Biliary, Tumor Necrosis Factor-alpha, Genome-Wide Association Study
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review